Identification of Potential Bioactive Compounds from Aspergillus terreus against HCV NS3 Serine Protease

Chem Biodivers. 2023 Aug;20(8):e202300532. doi: 10.1002/cbdv.202300532. Epub 2023 Jul 17.

Abstract

This study was aimed to isolate bioactive compounds from the fermentation products of Aspergillus terreus, which could inhibit NS3 protease of hepatitis C virus (HCV). The bioactive compounds were isolated by reverse-phase silica-gel column chromatography, semi-preparative reversed-phase, and Sephadex LH-20, and then their structures were elucidated through spectroscopic analysis. As a result, two small molecule compounds were isolated. Compound 1 was identified as a new benzaldehyde, (E)-2,4-dihydroxy-6-propenylbenzaldehyde. Compound 2 was identified as pleurone, which was obtained from microorganisms for the first time. Their inhibitory activities against HCV NS3 protease (IC50 ) were 32.6 μM and 78.9 μM, respectively. This study provided a new option for the development of anti-HCV drugs.

Keywords: Aspergillus terreus; HCV NS3 protease; antiviral; bioactive compound.

MeSH terms

  • Antiviral Agents* / chemistry
  • Antiviral Agents* / pharmacology
  • Hepacivirus
  • Protease Inhibitors / chemistry
  • Serine*
  • Viral Nonstructural Proteins

Substances

  • Serine
  • Antiviral Agents
  • Viral Nonstructural Proteins
  • Protease Inhibitors

Supplementary concepts

  • Aspergillus terreus